Basic Brief Report
Atg13 and FIP200 act independently of Ulk1 and Ulk2 in autophagy induction
Downloads and Tools
Volume 7, Issue 12 December 2011
Pages 1424 - 1433
http://dx.doi.org/10.4161/auto.7.12.18027
Keywords: Atg13, FIP200, Ulk1, Ulk2, autophagy
Authors: Sebastian Alers, Antje S. Löffler, Florian Paasch, Alexandra M. Dieterle, Hildegard Keppeler, Kirsten Lauber, David G. Campbell, Birgit Fehrenbacher, Martin Schaller, Sebastian Wesselborg and Björn Stork
View affiliations Hide affiliations
- Sebastian Alers
-
Department of Internal Medicine I; University Clinic of Tübingen; Tübingen, Germany
- Antje S. Löffler
-
Department of Internal Medicine I; University Clinic of Tübingen; Tübingen, Germany
Current Affiliation: Institute of Molecular Medicine; Heinrich-Heine-University; Düsseldorf, Germany
- Florian Paasch
-
Department of Internal Medicine I; University Clinic of Tübingen; Tübingen, Germany
Department of Molecular Cell Biology; Max Planck Institute of Biochemistry; Martinsried, Germany
- Alexandra M. Dieterle
-
Department of Internal Medicine I; University Clinic of Tübingen; Tübingen, Germany
- Hildegard Keppeler
-
Department of Internal Medicine I; University Clinic of Tübingen; Tübingen, Germany
- Kirsten Lauber
-
Molecular Oncology; Department of Radiation Oncology; Ludwig-Maximilians-University; Munich, Germany
- David G. Campbell
-
MRC Protein Phosphorylation Unit; College of Life Sciences; University of Dundee; Dundee, Scotland UK
- Birgit Fehrenbacher
-
Department of Dermatology; University of Tübingen; Tübingen, Germany
- Martin Schaller
-
Department of Dermatology; University of Tübingen; Tübingen, Germany
- Sebastian Wesselborg
-
Department of Internal Medicine I; University Clinic of Tübingen; Tübingen, Germany
Current Affiliation: Institute of Molecular Medicine; Heinrich-Heine-University; Düsseldorf, Germany
- Björn Stork
-
Corresponding author: bjoern.stork@uni-duesseldorf.de
Department of Internal Medicine I; University Clinic of Tübingen; Tübingen, Germany
Current Affiliation: Institute of Molecular Medicine; Heinrich-Heine-University; Düsseldorf, Germany
Abstract:
Under normal growth conditions the mammalian target of rapamycin complex 1 (mTORC1) negatively regulates the central autophagy regulator complex consisting of Unc-51-like kinases 1/2 (Ulk1/2), focal adhesion kinase family-interacting protein of 200 kDa (FIP200) and Atg13. Upon starvation, mTORC1-mediated repression of this complex is released, which then leads to Ulk1/2 activation. In this scenario, Atg13 has been proposed as an adaptor mediating the interaction between Ulk1/2 and FIP200 and enhancing Ulk1/2 kinase activity. Using Atg13-deficient cells, we demonstrate that Atg13 is indispensable for autophagy induction. We further show that Atg13 function strictly depends on FIP200 binding. In contrast, the simultaneous knockout of Ulk1 and Ulk2 did not have a similar effect on autophagy induction. Accordingly, the Ulk1-dependent phosphorylation sites we identified in Atg13 are expendable for this process. This suggests that Atg13 has an additional function independent of Ulk1/2 and that Atg13 and FIP200 act in concert during autophagy induction.
Received: March 28, 2011; Accepted: September 8, 2011
Preview: